Interpretive criteria for temocillin disk diffusion susceptibility testing
Authors:
- 1 February 1985
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 4 (1) , 30-33
Abstract
The susceptibility of 677 clinical bacterial isolates to temocillin was determined by broth microdilution and disk diffusion methods for the purpose of evaluating disks with three different temocillin concentrations and determining the temocillin disk diffusion interpretive criteria. The 60μg temocillin disk provided the highest interpretive accuracy (96.2 %), although the 30μg disk differed by having only three (1.2 %) additional minor interpretive errors. Based on available temocillin pharmacokinetics and recommended dosage schedules, the minimum inhibitory concentration breakpoints chosen were: ⩾ 32μg/ml = resistant and ⩽ 16μg/ml = susceptible. The corresponding disk diffusion zone diameter breakpoints for the 60μg disk were ⩽ 17 mm and ⩾ 21 mm; zone diameters of 18–20 mm were considered intermediate. For the 30μg disk these were ⩽ 15 mm, ⩾ 19 mm and 16–18 mm respectively.Keywords
This publication has 7 references indexed in Scilit:
- Temocillin: In vitro activity against 734 selected clinical isolates, including β-lactamase-producing strainsDiagnostic Microbiology and Infectious Disease, 1984
- Comparative in vitro and in vivo activity of temocillin (BRL 17421) and ampicillin against Haemophilus influenzae type bAntimicrobial Agents and Chemotherapy, 1983
- Antibacterial activity and beta-lactamase stability of temocillinAntimicrobial Agents and Chemotherapy, 1982
- In vitro activity of temocillin, a new beta-lactamase-stable penicillin active against enterobacteriaAntimicrobial Agents and Chemotherapy, 1982
- In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillinAntimicrobial Agents and Chemotherapy, 1982
- In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalisAntimicrobial Agents and Chemotherapy, 1982
- BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humansAntimicrobial Agents and Chemotherapy, 1981